TSNDF (TerrAscend) Long-Term Debt: $212.0 Mil (As of Mar. 2026)


TSNDF TerrAscend Corp TSNDF
32 GF Score
Price $0.63
GF Value $0.99
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is TerrAscend Long-Term Debt?

TerrAscend TSNDF +1.61% 32 Long-Term Debt is $212.0 Mil as of Mar. 2026. GuruFocus rates TSNDF with a GF Score™ of 32/100 and a GF Value™ of $0.99 (Possible Value Trap). The stock has 5 warning signs investors should review.

TerrAscend's Long-Term Debt for the quarter that ended in Mar. 2026 was $212.0 Mil.

TerrAscend's quarterly Long-Term Debt declined from Sep. 2025 ($211.9 Mil) to Dec. 2025 ($210.7 Mil) but then increased from Dec. 2025 ($210.7 Mil) to Mar. 2026 ($212.0 Mil).

TerrAscend's annual Long-Term Debt increased from Dec. 2023 ($68.9 Mil) to Dec. 2024 ($192.6 Mil) and increased from Dec. 2024 ($192.6 Mil) to Dec. 2025 ($210.7 Mil).

TerrAscend  (OTCPK:TSNDF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

TerrAscend Long-Term Debt Related Terms

TerrAscend Long-Term Debt Historical Data

* Premium members only.

The historical data trend for TerrAscend's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TerrAscend Long-Term Debt Chart

TerrAscend Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 171.16 145.85 68.90 192.58 210.74

TerrAscend Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 192.90 199.12 211.91 210.74 212.00
TSNDF
32GF Score
TerrAscend Corp TSNDF
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $212.0 Mil mean?
TerrAscend (TSNDF) has a Long-Term Debt of $212.0 Mil as of Mar. 2026.
Is TerrAscend's Long-Term Debt too high?
TerrAscend's current Long-Term Debt is $212.0 Mil. Overall, TerrAscend has a GF Score™ of 32/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TerrAscend's Long-Term Debt compare to ZTS and UTHR?
TerrAscend's Long-Term Debt of $212.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. TerrAscend's current Long-Term Debt is $212.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TerrAscend stock overvalued right now?
Based on GuruFocus' analysis, TerrAscend (TSNDF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.99, compared to a current price of $0.63 — trading 36.4% below its estimated fair value. The current Long-Term Debt is $212.0 Mil. TerrAscend's overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For TerrAscend (TSNDF), the current Long-Term Debt is $212.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TerrAscend (TSNDF) Overvalued in 2026?

Based on GuruFocus' analysis, TerrAscend stock appears to be undervalued. The current stock price of $0.63 is trading 36.4% below its estimated GF Value™ of $0.99. GuruFocus considers TerrAscend to be Possible Value Trap.

Key valuation signals for TSNDF:

  • Long-Term Debt: $212.0 Mil
  • GF Value™: $0.99 vs. price of $0.63 (36.4% below fair value)
  • GF Score™: 32/100 with 5 warning signs

No single metric tells the full story. See the TSNDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TerrAscend Business Description

Other Exchanges TED:GermanyTSND:Canada
Address 77 City Centre Drive, Suite 501, East Tower, Mississauga, ON, CAN, L5B 1M5
TerrAscend Corp is a company focused on creating and delivering cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. In addition, the firm operates in California, Maryland, New Jersey, and Pennsylvania, with retail operations in Ohio and Canada. It operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. The firm has one operating segment, being the cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States. The company generates key revenue from the United States.
32GF Score

Get the complete analysis for TSNDF

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.63
Price
$0.99
GF Value